PAUL ROBBINS: Open Payments
NPI 1780757237 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 9 payments from 4 companies in 2025. Trend: 2023 $257 · 2024 $150 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $251 |
| Neurocrine BioSciences, Inc. | 4 | $243 |
| ABBVIE INC. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: COBENFY, INGREZZA, VRAYLAR, UZEDY.
Industry payments across SC — which companies pay providers there.
